CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 1237733-1237934 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T70918","span":{"begin":0,"end":201},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The spectrum of associated symptoms varies with the target antigen and may include alterations of memory, behavior, cognition, psychosis, seizures, and dyskinesias, all part of anti-NMDAR encephalitis."}

{"project":"Epistemic_Statements","denotations":[{"id":"T2703","span":{"begin":0,"end":201},"obj":"Epistemic_statement"}],"text":"The spectrum of associated symptoms varies with the target antigen and may include alterations of memory, behavior, cognition, psychosis, seizures, and dyskinesias, all part of anti-NMDAR encephalitis."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T39","span":{"begin":0,"end":201},"obj":"Sentence"}],"text":"The spectrum of associated symptoms varies with the target antigen and may include alterations of memory, behavior, cognition, psychosis, seizures, and dyskinesias, all part of anti-NMDAR encephalitis."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T640","span":{"begin":127,"end":136},"obj":"Phenotype"},{"id":"T641","span":{"begin":138,"end":146},"obj":"Phenotype"},{"id":"T642","span":{"begin":152,"end":163},"obj":"Phenotype"},{"id":"T643","span":{"begin":188,"end":200},"obj":"Phenotype"}],"attributes":[{"id":"A640","pred":"hp_id","subj":"T640","obj":"http://purl.obolibrary.org/obo/HP_0000709"},{"id":"A641","pred":"hp_id","subj":"T641","obj":"http://purl.obolibrary.org/obo/HP_0001250"},{"id":"A642","pred":"hp_id","subj":"T642","obj":"http://purl.obolibrary.org/obo/HP_0100660"},{"id":"A643","pred":"hp_id","subj":"T643","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"The spectrum of associated symptoms varies with the target antigen and may include alterations of memory, behavior, cognition, psychosis, seizures, and dyskinesias, all part of anti-NMDAR encephalitis."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1616","span":{"begin":127,"end":136},"obj":"Disease"},{"id":"T1617","span":{"begin":188,"end":200},"obj":"Disease"},{"id":"T42263","span":{"begin":127,"end":136},"obj":"Disease"},{"id":"T29209","span":{"begin":188,"end":200},"obj":"Disease"}],"attributes":[{"id":"A1616","pred":"mondo_id","subj":"T1616","obj":"http://purl.obolibrary.org/obo/MONDO_0005485"},{"id":"A1617","pred":"mondo_id","subj":"T1617","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A15444","pred":"mondo_id","subj":"T42263","obj":"http://purl.obolibrary.org/obo/MONDO_0005485"},{"id":"A92194","pred":"mondo_id","subj":"T29209","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"}],"text":"The spectrum of associated symptoms varies with the target antigen and may include alterations of memory, behavior, cognition, psychosis, seizures, and dyskinesias, all part of anti-NMDAR encephalitis."}